Dashboard
Manage Tickers

HKMPYHikma Pharmaceuticals Plc


$ -0.50 (-0.98 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 472.20 $ -1.29 (-0.27 %)
DIA $ 416.54 $ -0.36 (-0.09 %)
SPY $ 561.96 $ -1.90 (-0.34 %)
TLT $ 99.68 $ -0.64 (-0.63 %)
GLD $ 235.48 $ -2.71 (-1.14 %)
$ 50.5
-- x --
-- x --
-- - --
$ 42.23 - $ 54.92
245
na
na
$ 0.46
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

shortage-relief-more-takedas-vyvanse-for-adhd-on-the-way-as-us-ramps-up-production
Shortage Relief: More Takeda's Vyvanse For...
09/06/2024 13:46:26

Increase in production of Takeda's ADHD drug Vyvanse, approved by DEA to address ongoing shortages both domestically and gl...

jazz-and-hikma-accused-of-delaying-sleep-disorder-generic-drug-to-maintain-high-prices
Jazz And Hikma Accused Of Delaying Sleep D...
08/28/2024 17:37:50

Jazz Pharmaceuticals and Hikma Pharmaceuticals will face trial over allegations of delaying a generic version of Xyrem, causing...

drug-shortages-in-focus-how-fdas-quest-for-new-methotrexate-suppliers-affects-the-cancer-treatment-landscape
Drug Shortages in Focus: How FDA's Quest f...
06/12/2023 14:16:55

The FDA is actively seeking new suppliers to address the shortages of methotrexate, a widely used cancer drug in short supply s...

amarin-shares-drop-67-as-court-invalidates-its-heart-drug-patent-for-vascepa
Amarin Shares Drop 67% As Court Invalidate...
03/31/2020 07:21:46

Core News & Articles
Stocks That Hit 52-Week Highs On Tuesday
12/10/2019 19:27:17

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION